I probably should explain for those new to the RAC story how bisantrene can be both approved and not approved. The original version of bisantrene was approved by the French regulators in 1988, but they were absorbed into the EMA. Since bisantrene was not on the market when this regulator merger happened, the approval for bisantrene did not make it onto the EMA approved drug list.
Cardioprotection thread, page-843
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |